本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Applied DNA Sciences

5.62
0.0000
成交量:- -
成交額:- -
市值:725.80萬
市盈率:0.03
高:5.62
開:5.62
低:5.62
收:5.62
52周最高:243.30
52周最低:2.13
股本:129.15萬
流通股本:52.00萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):211.51
每股收益(LYR):-1,366.3988
淨資產收益率:-137.05%
總資產收益率:-64.06%
市淨率:1.00
市盈率(LYR):0.00

資料載入中...

2022/08/02

SEC問詢函

CORRESP [Cover] - Correspondence
2022/08/02

SEC問詢函

CORRESP [Cover] - Correspondence
2022/08/02

重要事件披露

8-K - Current report
2022/08/01

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/07/28

重要事件披露

8-K - Current report
2022/07/27

重要事件披露

8-K - Current report
2022/07/25

SEC問詢函

CORRESP [Cover] - Correspondence
2022/07/19

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2022/05/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/12

重要事件披露

8-K - Current report
2022/02/23

重要事件披露

8-K - Current report
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/02/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/02/10

重要事件披露

8-K - Current report
2022/01/28

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/01/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/03

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/14

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/12/09

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]